Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Cyclerion Therapeutics Inc.
Headquarters: Cambridge, MA, United States of America
Website: https://cyclerion.com
Year Founded: 2019
Status: Public
Industry Sector: HealthTechnology
CEO: Regina Graul, PhD
Number Of Employees: 1
Enterprise Value: $4,875,960
PE Ratio: -2.02
Exchange/Ticker 1: NASDAQ:CYCN
Exchange/Ticker 2: N/A
Latest Market Cap: $6,693,900
BioCentury | Sep 8, 2023
Management Tracks
CRISPR CEO Kulkarni named chair as Novak departs
Plus: updates from Vividion, Rapport, One Biosciences, enGene, Anokion and more
BioCentury | Aug 25, 2023
Data Byte
A breakdown of 2023’s smaller series A class by development stage
Fewer rounds by preclinical companies a drag on series A financings
BioCentury | Mar 29, 2023
Management Tracks
Park joins HanAll as co-CEO
Plus: Lucy hires Winrow as CSO and an update from Duke Street
BioCentury | Jan 31, 2023
Management Tracks
Baxter’s Accogli named CEO of Chiesi
Plus: J&J CMO Waldstreicher retiring, and updates from the Broad Institute, Ring, Hansa, Vaccitech and Beyond Air
BioCentury | Oct 5, 2022
Management Tracks
Owkin finds new CBO in Sanofi SVP
Plus CEO Séjourné moves to Aurobac and updates from Quantum, BioHaven and more
BioCentury | Aug 29, 2022
Management Tracks
Executives say success in new era means re-learning leadership
Shaking up the C-suite with new skills, human and technical, will mean breaking a few eggs
BioCentury | Dec 16, 2021
Finance
Dec. 15 Quick Takes: Mythic Raises $103M series B
Plus: JPM goes virtual, Genenta’s IPO and updates from Travere, Boehringer, Sobi-Apellis, J&J, Calliditas and more
BioCentury | Aug 6, 2021
Management Tracks
New CMO, CSO at Black Diamond
Plus updates from Adaptive, Homology and more
BioCentury | Apr 2, 2021
Management Tracks
BeiGene unveils new CFO; plus Precigen, Alphamab, Flagship, Melinta, Immunome and more
BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) promoted SVP Julia Wang to CFO, effective June 30. Wang, who joined BeiGene last June, has held leadership roles in finance at Alexion Pharmaceuticals Inc.
BioCentury | Mar 25, 2021
Management Tracks
Galapagos promotes Filius to president, Litchfield named Merck CFO; plus moves at LianBio, Adverum, Fulcrum, Aptose, Cyclerion, Medigene, Apie and more
Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) promoted Bart Filius to president from CFO while remaining COO. CEO Onno van de Stolpe will be responsible for oversight of R&D activities. Caroline
Items per page:
1 - 10 of 20